| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/06/2001 | CN1297906A Human cell withering related protein 22 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297905A Human ribosomal protein L14.22 as one new kind of polypeptide and polynuceotides encoding this polypeptide |
| 06/06/2001 | CN1297904A Human cytokinin inducing-gene expressing protein 25 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297903A Human zinc-finger protein 70 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297902A Human reticulin 80 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297901A Human membrane binding protein 37 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297900A Human phospholipid bimolecular motion related protein 36 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297899A Human vacuole protein 13 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297898A Human beta-transduction element 72 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297897A New human oxyglutelinoid and its code sequence |
| 06/06/2001 | CN1297896A Method of extracting activated prothrombin X(FXa) effectively |
| 06/06/2001 | CN1297895A Mitochondrion carrier 30 as one kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297894A Gamma-cop protein 96 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CA2290031A1 Methods and means for inducing apoptosis by interference in rna processing |
| 06/05/2001 | US6242669 Pesticidal toxins and nucleotide sequences which encode these toxins |
| 06/05/2001 | US6242667 Transgenic organisms having tetracycline-regulated transcriptional regulatory systems |
| 06/05/2001 | US6242588 Polynucleotide which codes for a polypeptide having extracellular domain of defined amino acid sequence; diagnosis of urogenital disorders; anticarcinogenic agents; antifertility agents |
| 06/05/2001 | US6242587 Nucleotide and amino acid sequences for protein expressed in platelets that interacts with integrin alpha iib cytoplasmic domain to activate the fibrinogen receptor; drug screening of agonists and antagonists; anticoagulants; vectors; host cells |
| 06/05/2001 | US6242586 Amino acid sequence of t cell surface antigen; fusion proteins; treatment of autoimmune diseases; antiarthritic agents; antiinflammatory agents; immunosuppressants; diagnosis; recombinant production |
| 06/05/2001 | US6242585 Mycobacterium tuberculosis specific DNA fragment |
| 06/05/2001 | US6242584 Method for identifying mycobacterial species by comparative sequence analysis of rpoB gene |
| 06/05/2001 | US6242580 Single-chain forms of the glycoprotein hormone quartet |
| 06/05/2001 | US6242579 Antigen found on a small subset of human hematopoietic cells which binds to monoclonal antibody MG1 |
| 06/05/2001 | US6242577 Isolation and use fibronectin receptor |
| 06/05/2001 | US6242576 Antibodies which bind to protein coded by specific nucleotide sequence; diagnosis and therapy |
| 06/05/2001 | US6242575 Antibodies for detecting p27 protein |
| 06/05/2001 | US6242574 Antimicrobial proteins |
| 06/05/2001 | US6242572 Human G protein coupled lysophosphatidic acid receptor |
| 06/05/2001 | US6242571 Serological identification of cattle, sheep or goats infected with anaplasma species |
| 06/05/2001 | US6242570 Recombinant fusion protein of two or more erythropoietin molecules; has prolonged plasma half-life; treatment or prevention of anemia |
| 06/05/2001 | US6242569 Regulators of apoptosis |
| 06/05/2001 | US6242568 Zinc finger protein derivatives and methods therefor |
| 06/05/2001 | US6242567 Amino acid sequences of hexapeptide, heptapeptide, and polypeptides from late 64 kilodalton protein; diagnosis; vaccines |
| 06/05/2001 | US6242566 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 06/05/2001 | US6242564 Administering peptide of defined amino acid sequence |
| 06/05/2001 | US6242563 Peptide analogues |
| 06/05/2001 | US6242427 Methods of inhibiting phagocytosis |
| 06/05/2001 | US6242420 Effective for stimulating phytoalexin production or increased peroxidase activity |
| 06/05/2001 | US6242419 Genes encoding proteins expressed in lymph node stromal cells from flaky skin (fsn-/-) mice and their use in therapy. |
| 06/05/2001 | US6242418 Therapeutic uses of BPI protein products for human meningococcemia |
| 06/05/2001 | US6242416 Inhibition of β-amyloid binding to the p75 nerve growth factor receptor |
| 06/05/2001 | US6242259 Compositions and methods for packing of alphavirus vectors |
| 06/05/2001 | US6242255 Protein which induces interferon-gamma production by immunocompetent cell |
| 06/05/2001 | US6242254 Cell has dna encoding tetracycline responsive transcriptional activator linked to tissue-specific promoter and tetracycline operator minimal promoter linked to dna encoding sv40 t antigen; cell proliferation is controlled by tetracycline |
| 06/05/2001 | US6242251 Polynucleotide which codes for polypeptide receptor of defined amino acid sequence having affinity for neuropeptide y, pancreatic polypeptide, or peptide yy; transfected host cells; drug screening |
| 06/05/2001 | US6242250 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 06/05/2001 | US6242249 Nucleotide sequences of trigger factor chaperones from staphylococcus; diagnosis; probes; primers; vaccines; bactericides; bacteriostats; antibodies; drug screening |
| 06/05/2001 | US6242241 Nucleotide and amino acid sequences; transgenic plants; transformed host cells |
| 06/05/2001 | US6242238 Nucleotide sequence which codes for heparinase; drug screening for antimetastasis/antinflammatory agents, angiogenesis inhibitors, wound healing agents; treatment for angioplasty-induced restenosis and atherosclerosis |
| 06/05/2001 | US6242232 Amino acid and nucleotide sequences; recombinant production |
| 06/05/2001 | US6242219 Methods for recombinant peptide production |
| 06/05/2001 | US6242218 Dna construct for altering gene expression of endogenous granulocyte-colony stimulating factor in mammalian cell; gene therapy; culture production |
| 06/05/2001 | US6242217 Nucleotide sequence coding polypeptides for the treatment of cancer, cardiovascular diseases, inflammatory, kidneys defects, pain, psychological disorders and nervous system disorders |
| 06/05/2001 | US6242216 Nucleic acids encoding a functional human purinoreceptor P2X2 and P2X4, and methods of production and use thereof |
| 06/05/2001 | US6242214 Human GTPase-associated proteins |
| 06/05/2001 | US6242213 Nucleotide sequences coding preferential polypeptide for use in controlling immune response |
| 06/05/2001 | US6242212 Nucleotide sequences which code a protein for the diagnosis, detection and treatment of cancer |
| 06/05/2001 | US6242203 Tumor-specific P450 protein |
| 06/05/2001 | US6242201 Detection of protein that preferentially binds to proliferating cells; for the treatment of psoriasis, cancer and cell proliferative defect |
| 06/05/2001 | US6242199 Detecting ligand associated with hormone release; transform cells with vector, transform cells with vector coding light protein, incubate cells with binding protein, detect binding activity |
| 06/05/2001 | US6242185 Purified nucleic acid encoding transcription factor regulatory protein |
| 06/05/2001 | US6242183 Interaction trap systems for detecting protein interactions |
| 06/05/2001 | US6242176 Preventing viral joining to cells; incubation of cells with ligand and screen for deactivation of viral activity |
| 06/05/2001 | US6242174 Detecting antibodies generated from viral infection; analyze test samples in preferential mixtures designed to bind viral antigens |
| 06/05/2001 | US6241992 Bovine footrot treatment and prevention |
| 06/05/2001 | US6241989 Recombinant multivalent viral vaccine |
| 06/05/2001 | US6241982 Method for treating brain cancer with a conditionally lethal gene |
| 06/05/2001 | US6241965 Somatostatin derivatives and their radiolabelled products |
| 06/05/2001 | CA2192171C Process for the fractionation of whey constituents |
| 06/05/2001 | CA2168429C Expression of fusion polypeptides transported out of cytoplasm without leader sequences |
| 06/05/2001 | CA2155335C Improved method for the refolding of proteins |
| 06/05/2001 | CA2155185C Totally synthetic affinity reagents |
| 06/05/2001 | CA2112408C Monoclonal antibody to lymphocyte-associated cell surface protein |
| 06/05/2001 | CA2059647C Thiocylating reagents and intermediates, thiopeptides, and methods for preparing and using same |
| 06/05/2001 | CA2022650C Process for the preparation of a stable factor viii |
| 06/05/2001 | CA2005502C Somatotropin analogs |
| 06/05/2001 | CA1341245C Recombinant vaccinia virus mva |
| 06/05/2001 | CA1341242C Dna sequence, vectors, recombinant viruses, and process involving recombinant cowpox viruses capable of multiplying in cho cells |
| 06/05/2001 | CA1341241C Expression of a tumor-specific antigen through a recombinant virus vector, and its use for prevention or cure of the corresponding tumor |
| 06/05/2001 | CA1341240C Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide |
| 06/04/2001 | WO2001042474A2 Interferon-like molecules and uses thereof |
| 06/04/2001 | CA2395408A1 Interferon-like molecules and uses thereof |
| 06/03/2001 | CA2325169A1 Somatostatins and method |
| 06/01/2001 | CA2327140A1 Novel protein conjugates and process for the preparation thereof |
| 05/31/2001 | WO2001038872A2 Assay of isomerised and/or optically inverted proteins |
| 05/31/2001 | WO2001038584A2 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 05/31/2001 | WO2001038566A2 Screening method for candidate drugs |
| 05/31/2001 | WO2001038564A2 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy |
| 05/31/2001 | WO2001038551A1 Regulation of polycomb group gene expression for increasing seed size in plants |
| 05/31/2001 | WO2001038550A2 Methods for altering the expression of hyphal-specific genes |
| 05/31/2001 | WO2001038549A1 Compositions and methods utilizing sequences for controlling nucleic acid expression in yeast |
| 05/31/2001 | WO2001038547A2 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 05/31/2001 | WO2001038544A1 Method for purifying proteins |
| 05/31/2001 | WO2001038541A1 Moss genes from physcomitrella patents encoding proteins involved in the synthesis of polyunsaturated fatty acids and lipids |
| 05/31/2001 | WO2001038537A1 Method of constructing cell-fusion type morbillivirus mutant |
| 05/31/2001 | WO2001038535A1 Chimeric gene enabling expression of the gene or cdna of type i insulin-like growth factor (igf-i) in the pancreas and utilization thereof in genic therapy of diabetes mellitus |
| 05/31/2001 | WO2001038534A2 Human serpin |
| 05/31/2001 | WO2001038533A2 G protein-coupled receptor-like receptors and modulators thereof |
| 05/31/2001 | WO2001038532A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 05/31/2001 | WO2001038531A1 Human nucleoprotein having www domain and polynucleotide encoding the same |